（文章来源：每日经济新闻） 每经AI快讯，1月15日，港股东曜药业-B、元续科技今日复牌。 ...

Company News - CITIC Securities (06030.HK) reported a revenue of RMB 74.83 billion for the fiscal year 2025, representing a year-on-year increase of 28.75%, and a net profit of RMB 30.05 billion, up 38.46% year-on-year [2] - CITIC Bank (00998.HK) announced a total revenue of RMB 212.48 billion for 2025, a slight decrease of 0.55% year-on-year, while net profit increased by 2.98% to RMB 70.62 billion [2] - Beijing North Star Industrial (00588.HK) expects to continue reporting losses for the fiscal year ending December 31, 2025 [3] - Yuexiu Property (00123.HK) reported a cumulative contract sales amount of approximately RMB 106.21 billion for 2025, a decline of about 7.3% year-on-year, achieving 88.1% of its sales target [3] - Jiao Ge Peng You Holdings (01450.HK) achieved a total GMV of approximately RMB 6.49 billion in Q4 2025, a year-on-year increase of about 4.34%, with a cumulative GMV of RMB 16.02 billion for the year, up 6.23% [3] - Sai Jing Technology (00580.HK) anticipates a revenue of approximately RMB 2.25 billion for 2025, reflecting a year-on-year increase of about 40% due to increased revenue from flexible transmission business [3] - China General Nuclear Power New Energy (01811.HK) reported a cumulative power generation of 19,000 GWh for 2025, a decrease of 0.8% year-on-year, with variations in different energy sources [3] - Morning News Technology (02000.HK) reported an unaudited revenue of HKD 397 million for 2025, a decrease of 7.4% year-on-year [3] Financing and Buyback Activities - Chow Tai Fook Enterprises (00659.HK) applied for the registration of debt financing instruments totaling no more than RMB 5 billion [7] - Tencent Holdings (00700.HK) repurchased 1.006 million shares at a cost of approximately HKD 636 million, with repurchase prices ranging from HKD 626 to HKD 638 [7] - Xiaomi Group-W (01810.HK) repurchased 4 million shares for approximately HKD 151 million, with repurchase prices between HKD 37.61 and HKD 42.50 [7] Research and Development - Hutchison China MediTech (00013.HK) announced the publication of SACHI III study results in The Lancet [4] - Laka Pharmaceuticals-B (02105.HK) had its clinical trial application for the new drug LAE118 accepted by the U.S. FDA [5] Other News - Yuanxu Technology (08637.HK) announced a short suspension of trading starting January 14, pending the release of insider information [6] - Haidilao (06862.HK) redeemed USD 600 million of its 2.150% notes due in 2026 [2]

Group 1 - The company, Yuanxu Technology (08637.HK), is considering applying for a dual primary listing on the Singapore Exchange (SGX) to enhance its corporate image and broaden its shareholder base [1] - The company has submitted an application to the Hong Kong Stock Exchange (HKEX) for its shares to resume trading on January 15, 2026, at 9:00 AM [1] - The dual listing is contingent upon meeting the requirements and conditions set by the SGX, as well as applicable laws, rules, and regulations [1]

Core Viewpoint - Yuanxu Technology (08637) is considering applying for a dual primary listing on the Singapore Exchange to enhance its corporate image and broaden its shareholder base, pending compliance with relevant requirements and regulations [1] Group 1: Listing Strategy - The company is exploring the possibility of a dual primary listing on the Singapore Exchange, alongside its existing listing on the Hong Kong Stock Exchange [1] - Professional advisors have been appointed to provide guidance on the proposed listing, although a formal application has not yet been submitted [1] Group 2: Trading Resumption - The company has applied to the Hong Kong Stock Exchange for its shares to resume trading starting from January 15, 2026, at 9:00 AM [1]

智通财经APP讯，元续科技(08637)发布公告，基于业务策略及发展考量，并为了进一步提升企业形象及 扩阔公司股东基础，公司正考虑申请将其股份于新加坡交易所证券交易有限公司凯利板上市，以期于联 交所及新交所双重主要上市，惟须符合新交所的要求及╱或条件以及适用法律、规则及法规。 于本公告日期，公司已委聘专业顾问就建议上市提供意见，但尚未提交正式上市申请。 公司已向联交所申请股份自2026年1月15日(星期四)上午九时正起恢复于联交所买卖。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 （股份代號：8637） 內幕消息 可能於新交所上市 及恢復買賣 本公告乃由元續科技控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）根據 香港聯合交易所有限公司（「聯交所」）GEM證券上市規則（「上市規則」）第17.10條及 證券及期貨條例（香港法例第571章）第XIVA部項下的內幕消息條文（定義見上市規 則）作出。 本公司董事會（「董事會」）謹此通知本公司股東（「股東」）及潛在投資者，基於業務策 略及發展考量，並為了進一步提升企業形象及擴闊本公司股東基礎，本公司正考慮 申請將其股份（「股份」）於新加坡交易所證券交易有限公司（「新交所」）凱利板上市 （「建議上市」），以期於聯交所及新交所雙重主要上市，惟須符合新交所的要求 及╱或條件以及適用法律、規則及法規。 於本公告日期，本公司已委聘專業顧問就建議上市提供意見，但尚未提交正式上市 申請。本公司將於必要時根據適用法律、規則及法規（包括但不限於上市規 ...

元续科技(08637)发布公告，应公司要求，公司股票将于2026年1月14日上午9点起停止交易，以待公司 发布载有内幕资讯的公告。 ...

智通财经APP讯，元续科技(08637)发布公告，应公司要求，公司股票将于2026年1月14日上午9点起停止 交易，以待公司发布载有内幕资讯的公告。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告的內容概不負責， 對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何 部份內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 元續科技控股有限公司董事會（分別稱為「董事會」和「本公司」）宣布，應公司要求， 公司股票將於2026年1月14日上午9點起停止交易，以待公司發布載有內幕資訊的公 告。 承董事會命 元續科技控股有限公司 主席、行政總裁兼執行董事 蔡水理 新加坡，2026年1月14日 元 續 科技控股有限公司 （於開曼群島註冊成立的有限公司） （股份代號：8637） METASURFACE TECHNOLOGIES HOLDINGS LIMITED 短暫停牌 本公告乃遵照香港聯合交易所有限公司GEM證券上市規則而提供有關本公司的資 料，董事願就此共同及個別地承擔全部責任。董事經作出一切合理查詢後，確認就 彼等所深知及確信，本公告所載資料於所有重要方面均屬準確及完備，並無誤導或 欺詐成分；及並無遺漏任何其他事項，足以令致本公告所載任何陳述或本公告產生 誤導。 – 1 – 本公告可於本公司網站www.metatechnolog ...

智通财经APP讯，元续科技(08637)发布公告，公司股份将于2026年1月14日上午9时正起短暂停止买卖。 （原标题：元续科技(08637)1月14日起短暂停牌） ...